VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.96 USD | +0.74% |
|
+1.76% | -3.77% |
| May. 13 | Ventas Insider Sold Shares Worth $697,653, According to a Recent SEC Filing | MT |
| May. 10 | Jefferies Adjusts Price Target on Ventas to $56 From $52 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 4.83B | Sales 2025 * | 5.08B | Capitalization | 19.27B |
|---|---|---|---|---|---|
| Net income 2024 * | -198M | Net income 2025 * | -97M | EV / Sales 2024 * | 6.67 x |
| Net Debt 2024 * | 12.91B | Net Debt 2025 * | 13.08B | EV / Sales 2025 * | 6.37 x |
| P/E ratio 2024 * |
-70.4
x | P/E ratio 2025 * |
-66.7
x | Employees | 486 |
| Yield 2024 * |
3.79% | Yield 2025 * |
4.01% | Free-Float | 99.42% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More news
| 1 day | +0.74% | ||
| 1 week | +1.76% | ||
| Current month | +8.31% | ||
| 1 month | +13.54% | ||
| 3 months | +5.15% | ||
| 6 months | +7.75% | ||
| Current year | -3.77% |
1 week
46.82
48.16
1 month
41.4548.16
Current year
41.4550.61
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 59 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 197 M€ | -.--% | ||
| 1.91% | 258 M€ | -1.32% | ||
| 1.43% | 133 M€ | +5.18% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 47.96 | +0.74% | 1,647,362 |
| 24-05-13 | 47.61 | +0.11% | 1,151,597 |
| 24-05-10 | 47.56 | +0.02% | 1,148,974 |
| 24-05-09 | 47.55 | +0.23% | 1,930,781 |
| 24-05-08 | 47.44 | +0.66% | 2,637,420 |
Delayed Quote Nyse, May 14, 2024 at 04:00 pm EDT
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
47.61
USD
Average target price
53.21
USD
Spread / Average Target
+11.76%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.77% | 19.27B | |
| +9.59% | 59.48B | |
| +0.10% | 13.77B | |
| +0.65% | 7.6B | |
| -7.08% | 6.06B | |
| +11.17% | 3.52B | |
| +2.94% | 3.35B | |
| +19.14% | 3.35B | |
| -3.46% | 3.21B | |
| +19.52% | 2.86B |
- Stock Market
- Equities
- VTR Stock
